New York State Common Retirement Fund Has $50.46 Million Stock Position in Amdocs Limited (NASDAQ:DOX)

New York State Common Retirement Fund increased its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 574,155 shares of the technology company's stock after purchasing an additional 32,921 shares during the period. New York State Common Retirement Fund owned 0.49% of Amdocs worth $50,462,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Operose Advisors LLC lifted its stake in shares of Amdocs by 148.0% in the 3rd quarter. Operose Advisors LLC now owns 310 shares of the technology company's stock valued at $26,000 after purchasing an additional 185 shares during the period. Oakworth Capital Inc. acquired a new position in shares of Amdocs in the 4th quarter valued at $26,000. VisionPoint Advisory Group LLC lifted its stake in shares of Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company's stock valued at $42,000 after purchasing an additional 220 shares during the period. Allworth Financial LP lifted its stake in shares of Amdocs by 16,840.0% in the 3rd quarter. Allworth Financial LP now owns 847 shares of the technology company's stock valued at $72,000 after purchasing an additional 842 shares during the period. Finally, Quent Capital LLC lifted its stake in shares of Amdocs by 27.3% in the 4th quarter. Quent Capital LLC now owns 1,148 shares of the technology company's stock valued at $101,000 after purchasing an additional 246 shares during the period. Institutional investors own 92.02% of the company's stock.

Amdocs Trading Up 0.2 %

Shares of NASDAQ DOX traded up $0.17 during midday trading on Wednesday, reaching $86.74. 485,086 shares of the stock were exchanged, compared to its average volume of 651,304. The business has a 50-day simple moving average of $89.93 and a two-hundred day simple moving average of $87.33. The company has a market capitalization of $10.20 billion, a price-to-earnings ratio of 18.47, a P/E/G ratio of 1.40 and a beta of 0.69. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same period last year, the business posted $1.33 earnings per share. The firm's quarterly revenue was up 5.0% on a year-over-year basis. As a group, equities research analysts expect that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.21%. This is a positive change from Amdocs's previous quarterly dividend of $0.44. The ex-dividend date is Wednesday, March 27th. Amdocs's dividend payout ratio (DPR) is presently 41.11%.

Analysts Set New Price Targets

DOX has been the topic of a number of analyst reports. Barclays increased their price target on Amdocs from $105.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, February 8th. Citigroup lifted their price target on shares of Amdocs from $96.00 to $104.00 and gave the stock a "buy" rating in a research report on Wednesday, January 17th. Finally, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, March 15th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $108.60.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.